Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by University of Michigan Cancer Center
Sponsor:
Information provided by (Responsible Party):
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT01663272
First received: July 24, 2012
Last updated: October 16, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)